Literature DB >> 30004258

Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.

Linda Alex1, Ilaria Russo1, Volodymir Holoborodko1, Nikolaos G Frangogiannis1.   

Abstract

Heart failure with preserved ejection fraction (HFpEF) is caused, or exacerbated by, a wide range of extracardiac conditions. Diabetes, obesity, and metabolic dysfunction are associated with a unique HFpEF phenotype, characterized by inflammation, cardiac fibrosis, and microvascular dysfunction. Development of new therapies for HFpEF is hampered by the absence of reliable animal models. The leptin-resistant db/ db mouse has been extensively studied as a model of diabetes-associated cardiomyopathy; however, data on the functional and morphological alterations in db/ db hearts are conflicting. In the present study, we report a systematic characterization of the cardiac phenotype in db/ db mice, focusing on the time course of functional and histopathological alterations and on the identification of sex-specific cellular events. Although both male and female db/ db mice developed severe obesity, increased adiposity, and hyperglycemia, female mice had more impressive weight gain and exhibited a modest but significant increase in blood pressure. db/ db mice had hypertrophic ventricular remodeling and diastolic dysfunction with preserved ejection fraction; the increase in left ventricular mass was accentuated in female mice. Histological analysis showed that both male and female db/ db mice had cardiomyocyte hypertrophy and interstitial fibrosis, associated with marked thickening of the perimysial collagen, and expansion of the periarteriolar collagen network, in the absence of replacement fibrosis. In vivo and in vitro experiments showed that fibrotic changes in db/ db hearts were associated with increased collagen synthesis by cardiac fibroblasts, in the absence of periostin, α-smooth muscle actin, or fibroblast activation protein overexpression. Male db/ db mice exhibited microvascular rarefaction. In conclusion, the db/ db mouse model recapitulates functional and histological features of human HFpEF associated with metabolic dysfunction. Development of fibrosis in db/ db hearts, in the absence of myofibroblast conversion, suggests that metabolic dysfunction may activate an alternative profibrotic pathway associated with accentuated extracellular matrix protein synthesis. NEW & NOTEWORTHY We provide a systematic analysis of the sex-specific functional and structural myocardial alterations in db/ db mice. Obese diabetic C57BL6J db/ db mice exhibit diastolic dysfunction with preserved ejection fraction, associated with cardiomyocyte hypertrophy, interstitial/perivascular fibrosis, and microvascular rarefaction, thus recapitulating aspects of human obesity-related heart failure with preserved ejection fraction. Myocardial fibrosis in db/ db mice is associated with a matrix-producing fibroblast phenotype, in the absence of myofibroblast conversion, suggesting an alternative mechanism of activation.

Entities:  

Keywords:  diabetes; diastolic dysfunction; fibroblast; fibrosis; hypertrophy

Mesh:

Substances:

Year:  2018        PMID: 30004258      PMCID: PMC6230908          DOI: 10.1152/ajpheart.00238.2018

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  59 in total

1.  Pulsed Doppler signal processing for use in mice: applications.

Authors:  Anilkumar K Reddy; George E Taffet; Yi-Heng Li; Sang-Wook Lim; Thuy T Pham; Jennifer S Pocius; Mark L Entman; Lloyd H Michael; Craig J Hartley
Journal:  IEEE Trans Biomed Eng       Date:  2005-10       Impact factor: 4.538

2.  Enhanced left ventricular systolic function early in type 2 diabetic mice: clinical implications.

Authors:  Jorge A Alvarez; Maricela Reyes; Daniel Escobedo; Gregory L Freeman; Mark E Steinhelper; Marc D Feldman
Journal:  Diab Vasc Dis Res       Date:  2004-10       Impact factor: 3.291

Review 3.  Epidemiology of heart failure with preserved ejection fraction.

Authors:  Shannon M Dunlay; Véronique L Roger; Margaret M Redfield
Journal:  Nat Rev Cardiol       Date:  2017-05-11       Impact factor: 32.419

4.  Obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a Western diet.

Authors:  Camila Manrique; Vincent G DeMarco; Annayya R Aroor; Irina Mugerfeld; Mona Garro; Javad Habibi; Melvin R Hayden; James R Sowers
Journal:  Endocrinology       Date:  2013-07-24       Impact factor: 4.736

5.  Rac1 is required for cardiomyocyte apoptosis during hyperglycemia.

Authors:  E Shen; Yanwen Li; Ying Li; Limei Shan; Huaqing Zhu; Qingping Feng; J Malcolm O Arnold; Tianqing Peng
Journal:  Diabetes       Date:  2009-07-10       Impact factor: 9.461

6.  Ultrastructural localization of concanavalin A and wheat germ agglutinin binding sites in adult and embryonic mouse myocardium.

Authors:  D Gros; B Bruce; C E Challice; J Schrevel
Journal:  J Histochem Cytochem       Date:  1982-03       Impact factor: 2.479

7.  Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness.

Authors:  An Van den Bergh; Annelies Vanderper; Peter Vangheluwe; Fanny Desjardins; Ines Nevelsteen; Wim Verreth; Frank Wuytack; Paul Holvoet; Willem Flameng; Jean-Luc Balligand; Paul Herijgers
Journal:  Cardiovasc Res       Date:  2007-08-14       Impact factor: 10.787

8.  Novel Index of Maladaptive Myocardial Remodeling in Hypertension.

Authors:  Vera J Goh; Thu-Thao Le; Jennifer Bryant; Jia Ing Wong; Boyang Su; Chi-Hang Lee; Chee Jian Pua; Chloe P Y Sim; Briana Ang; Tar Choon Aw; Stuart A Cook; Calvin W L Chin
Journal:  Circ Cardiovasc Imaging       Date:  2017-09       Impact factor: 7.792

9.  Diastolic dysfunction is more apparent in STZ-induced diabetic female mice, despite less pronounced hyperglycemia.

Authors:  Chanchal Chandramouli; Melissa E Reichelt; Claire L Curl; Upasna Varma; Laura A Bienvenu; Parisa Koutsifeli; Antonia J A Raaijmakers; Miles J De Blasio; Cheng Xue Qin; Alicia J Jenkins; Rebecca H Ritchie; Kimberley M Mellor; Lea M D Delbridge
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

10.  Zinc Prevents the Development of Diabetic Cardiomyopathy in db/db Mice.

Authors:  Shudong Wang; Bowei Wang; Yuehui Wang; Qian Tong; Quan Liu; Jian Sun; Yang Zheng; Lu Cai
Journal:  Int J Mol Sci       Date:  2017-03-07       Impact factor: 5.923

View more
  55 in total

1.  Renal Denervation to Treat Heart Failure.

Authors:  Thomas E Sharp; David J Lefer
Journal:  Annu Rev Physiol       Date:  2020-10-19       Impact factor: 19.318

2.  Validation of diagnostic criteria and histopathological characterization of cardiac rupture in the mouse model of nonreperfused myocardial infarction.

Authors:  Anis Hanna; Arti V Shinde; Nikolaos G Frangogiannis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-09-04       Impact factor: 4.733

3.  The relationship between coronary microvascular dysfunction, atrial fibrillation and heart failure with preserved ejection fraction.

Authors:  Cevher Ozcan; Tess Allan; Stephanie A Besser; Anthony de la Pena; John Blair
Journal:  Am J Cardiovasc Dis       Date:  2021-02-15

Review 4.  The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.

Authors:  Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2019-06-20       Impact factor: 17.367

Review 5.  Disruption of energy utilization in diabetic cardiomyopathy; a mini review.

Authors:  Shinsuke Nirengi; Carmem Peres Valgas da Silva; Kristin I Stanford
Journal:  Curr Opin Pharmacol       Date:  2020-09-25       Impact factor: 5.547

6.  Deficit of resolution receptor magnifies inflammatory leukocyte directed cardiorenal and endothelial dysfunction with signs of cardiomyopathy of obesity.

Authors:  Bochra Tourki; Vasundhara Kain; Saame Raza Shaikh; Xavier Leroy; Charles N Serhan; Ganesh V Halade
Journal:  FASEB J       Date:  2020-06-16       Impact factor: 5.191

Review 7.  The role of Smad signaling cascades in cardiac fibrosis.

Authors:  Anis Hanna; Claudio Humeres; Nikolaos G Frangogiannis
Journal:  Cell Signal       Date:  2020-11-05       Impact factor: 4.315

Review 8.  Cardiac fibrosis.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

9.  CD133+Exosome Treatment Improves Cardiac Function after Stroke in Type 2 Diabetic Mice.

Authors:  Poornima Venkat; Chengcheng Cui; Zhili Chen; Michael Chopp; Alex Zacharek; Julie Landschoot-Ward; Lauren Culmone; Xiao-Ping Yang; Jiang Xu; Jieli Chen
Journal:  Transl Stroke Res       Date:  2020-03-20       Impact factor: 6.829

Review 10.  Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches.

Authors:  Begoña López; Susana Ravassa; María U Moreno; Gorka San José; Javier Beaumont; Arantxa González; Javier Díez
Journal:  Nat Rev Cardiol       Date:  2021-02-10       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.